View Financial HealthAether Industries 배당 및 자사주 매입배당 기준 점검 0/6Aether Industries 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률-0.03%자사주 매입 수익률총 주주 수익률-0.03%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updatesReported Earnings • May 18Full year 2026 earnings: EPS misses analyst expectationsFull year 2026 results: EPS: ₹16.55 (up from ₹11.95 in FY 2025). Revenue: ₹11.8b (up 41% from FY 2025). Net income: ₹2.19b (up 39% from FY 2025). Profit margin: 19% (in line with FY 2025). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 5.0%. Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Pharmaceuticals industry in India. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.공시 • May 05Aether Industries Limited to Report Q4, 2026 Results on May 15, 2026Aether Industries Limited announced that they will report Q4, 2026 results on May 15, 2026Valuation Update With 7 Day Price Move • Mar 20Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,161, the stock trades at a forward P/E ratio of 54x. Average forward P/E is 26x in the Pharmaceuticals industry in India. Total returns to shareholders of 31% over the past three years.Price Target Changed • Feb 05Price target increased by 10.0% to ₹1,154Up from ₹1,049, the current price target is an average from 5 analysts. New target price is 13% above last closing price of ₹1,023. Stock is up 20% over the past year. The company is forecast to post earnings per share of ₹17.58 for next year compared to ₹11.95 last year.Reported Earnings • Feb 04Third quarter 2026 earnings: EPS and revenues exceed analyst expectationsThird quarter 2026 results: EPS: ₹4.86 (up from ₹3.27 in 3Q 2025). Revenue: ₹3.17b (up 44% from 3Q 2025). Net income: ₹644.8m (up 49% from 3Q 2025). Profit margin: 20% (in line with 3Q 2025). Revenue exceeded analyst estimates by 10.0%. Earnings per share (EPS) also surpassed analyst estimates by 19%. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Pharmaceuticals industry in India. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.공시 • Jan 21Aether Industries Limited to Report Q3, 2026 Results on Feb 03, 2026Aether Industries Limited announced that they will report Q3, 2026 results on Feb 03, 2026Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹1,000, the stock trades at a forward P/E ratio of 52x. Average forward P/E is 28x in the Pharmaceuticals industry in India. Total returns to shareholders of 16% over the past three years.Valuation Update With 7 Day Price Move • Nov 20Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹893, the stock trades at a forward P/E ratio of 46x. Average forward P/E is 28x in the Pharmaceuticals industry in India. Total loss to shareholders of 2.1% over the past three years.Reported Earnings • Nov 14Second quarter 2026 earnings released: EPS: ₹4.07 (vs ₹2.63 in 2Q 2025)Second quarter 2026 results: EPS: ₹4.07 (up from ₹2.63 in 2Q 2025). Revenue: ₹2.84b (up 43% from 2Q 2025). Net income: ₹539.6m (up 55% from 2Q 2025). Profit margin: 19% (up from 18% in 2Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in India. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.공시 • Oct 04Aether Industries Limited to Report Q2, 2026 Results on Nov 13, 2025Aether Industries Limited announced that they will report Q2, 2026 results on Nov 13, 2025Reported Earnings • Jul 25First quarter 2026 earnings: EPS exceeds analyst expectationsFirst quarter 2026 results: EPS: ₹3.55 (up from ₹2.26 in 1Q 2025). Revenue: ₹2.59b (up 44% from 1Q 2025). Net income: ₹470.2m (up 57% from 1Q 2025). Profit margin: 18% (up from 17% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.4%. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Pharmaceuticals industry in India. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has fallen by 3% per year.공시 • Jul 24Aether Industries Limited, Annual General Meeting, Sep 12, 2025Aether Industries Limited, Annual General Meeting, Sep 12, 2025.공시 • Jun 30Aether Industries Limited to Report Q1, 2026 Results on Jul 24, 2025Aether Industries Limited announced that they will report Q1, 2026 results on Jul 24, 2025공시 • May 15An undisclosed buyer acquired 6.77% stake in Aether Industries Limited (NSEI:AETHER) from Purnima Ashwin Desai for INR 6.3 billion.An undisclosed buyer acquired 6.77% stake in Aether Industries Limited (NSEI:AETHER) from Purnima Ashwin Desai for INR 6.3 billion on May 14, 2025. A cash consideration valued at INR 700 per share will be paid for 8.979173 million shares. An undisclosed buyer completed the acquisition of 6.77% stake in Aether Industries Limited (NSEI:AETHER) from Purnima Ashwin Desai on May 14, 2025.New Risk • May 08New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 27% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. This is currently the only risk that has been identified for the company.Reported Earnings • May 03Full year 2025 earnings: EPS and revenues exceed analyst expectationsFull year 2025 results: EPS: ₹11.95 (up from ₹6.31 in FY 2024). Revenue: ₹8.80b (up 47% from FY 2024). Net income: ₹1.58b (up 92% from FY 2024). Profit margin: 18% (up from 14% in FY 2024). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) also surpassed analyst estimates by 4.7%. Revenue is forecast to grow 28% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Pharmaceuticals industry in India.공시 • Apr 26Aether Industries Limited to Report Q4, 2025 Results on May 02, 2025Aether Industries Limited announced that they will report Q4, 2025 results on May 02, 2025Board Change • Apr 09Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. 4 highly experienced directors. Non-Executive Independent Director Rajkumar Borana was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.공시 • Jan 17Aether Industries Limited Provides Revenue Guidance for the Financial Year 2024Aether Industries Limited provided revenue guidance for the financial year 2024. The company anticipates net financial year to close to reach a revenue of INR 400 million.공시 • Jan 09Aether Industries Limited Announces Revocation Order from GPCB for Resumption of Operations at Manufacturing Facility IIAether Industries Limited announced that the Gujarat Pollution Control Board (GPCB), through its communication received January 9, 2025, has revoked the closure order issued on November 29, 2023, following the fire incident, for Manufacturing Facility II. Consequently, the facility is now approved for 100% resumption of operations. The Company will commence full-capacity operations at Manufacturing Facility II upon ensuring compliance with the stipulated conditions.공시 • Jan 01Aether Industries Limited to Report Q3, 2025 Results on Jan 17, 2025Aether Industries Limited announced that they will report Q3, 2025 results on Jan 17, 2025Board Change • Dec 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. 4 highly experienced directors. Non-Executive Independent Director Rajkumar Borana was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 19Second quarter 2025 earnings released: EPS: ₹2.87 (vs ₹2.77 in 2Q 2024)Second quarter 2025 results: EPS: ₹2.87 (up from ₹2.77 in 2Q 2024). Revenue: ₹2.09b (up 27% from 2Q 2024). Net income: ₹380.7m (up 3.8% from 2Q 2024). Profit margin: 18% (down from 22% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 36% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in India.공시 • Oct 04Aether Industries Limited to Report Q2, 2025 Results on Oct 18, 2024Aether Industries Limited announced that they will report Q2, 2025 results on Oct 18, 2024공시 • Jul 22Aether Industries Limited, Annual General Meeting, Sep 10, 2024Aether Industries Limited, Annual General Meeting, Sep 10, 2024.Reported Earnings • Jul 21First quarter 2025 earnings released: EPS: ₹2.26 (vs ₹2.25 in 1Q 2024)First quarter 2025 results: EPS: ₹2.26 (up from ₹2.25 in 1Q 2024). Revenue: ₹1.80b (up 12% from 1Q 2024). Net income: ₹299.3m (flat on 1Q 2024). Profit margin: 17% (down from 19% in 1Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 33% p.a. on average during the next 3 years, compared to a 9.9% growth forecast for the Pharmaceuticals industry in India.공시 • Jul 04Aether Industries Limited to Report Q1, 2025 Results on Jul 19, 2024Aether Industries Limited announced that they will report Q1, 2025 results on Jul 19, 2024New Risk • Jun 05New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 14% Last year net profit margin: 20% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (37% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (14% net profit margin). Shareholders have been diluted in the past year (6.5% increase in shares outstanding).Reported Earnings • Feb 02Third quarter 2024 earnings released: EPS: ₹1.32 (vs ₹2.81 in 3Q 2023)Third quarter 2024 results: EPS: ₹1.32 (down from ₹2.81 in 3Q 2023). Revenue: ₹1.67b (flat on 3Q 2023). Net income: ₹174.3m (down 50% from 3Q 2023). Profit margin: 11% (down from 21% in 3Q 2023). Revenue is forecast to grow 36% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Pharmaceuticals industry in India.공시 • Jan 16Aether Industries Limited to Report Q3, 2024 Results on Feb 01, 2024Aether Industries Limited announced that they will report Q3, 2024 results on Feb 01, 2024Reported Earnings • Nov 02Second quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2024 results: EPS: ₹2.77 (up from ₹2.19 in 2Q 2023). Revenue: ₹1.78b (up 27% from 2Q 2023). Net income: ₹366.8m (up 35% from 2Q 2023). Profit margin: 21% (up from 19% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 7.5%. Earnings per share (EPS) exceeded analyst estimates by 11%. Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Pharmaceuticals industry in India.공시 • Oct 20Aether Industries Limited to Report Q2, 2024 Results on Oct 31, 2023Aether Industries Limited announced that they will report Q2, 2024 results on Oct 31, 2023Reported Earnings • Jul 27First quarter 2024 earnings released: EPS: ₹2.25 (vs ₹2.46 in 1Q 2023)First quarter 2024 results: EPS: ₹2.25 (down from ₹2.46 in 1Q 2023). Revenue: ₹1.61b (flat on 1Q 2023). Net income: ₹298.1m (down 2.6% from 1Q 2023). Profit margin: 19% (in line with 1Q 2023). Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Pharmaceuticals industry in India.공시 • Jul 12Aether Industries Limited to Report Q1, 2024 Results on Jul 26, 2023Aether Industries Limited announced that they will report Q1, 2024 results on Jul 26, 2023New Risk • Jun 24New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 6.5% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (60% accrual ratio). Minor Risk Shareholders have been diluted in the past year (6.5% increase in shares outstanding).공시 • Jun 24Aether Industries Limited has completed a Follow-on Equity Offering in the amount of INR 7.5 billion.Aether Industries Limited has completed a Follow-on Equity Offering in the amount of INR 7.5 billion. Security Name: Equity Shares Security Type: Common Stock Securities Offered: 8,012,820 Price\Range: INR 936 Transaction Features: Regulation S; Subsequent Direct ListingReported Earnings • May 08Full year 2023 earnings released: EPS: ₹10.47 (vs ₹9.67 in FY 2022)Full year 2023 results: EPS: ₹10.47 (up from ₹9.67 in FY 2022). Revenue: ₹6.68b (up 13% from FY 2022). Net income: ₹1.30b (up 20% from FY 2022). Profit margin: 20% (up from 18% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 28% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Pharmaceuticals industry in India.공시 • May 07Aether Industries Limited, Annual General Meeting, Jun 16, 2023Aether Industries Limited, Annual General Meeting, Jun 16, 2023.Reported Earnings • Jan 22Third quarter 2023 earnings released: EPS: ₹2.81 (vs ₹2.28 in 3Q 2022)Third quarter 2023 results: EPS: ₹2.81 (up from ₹2.28 in 3Q 2022). Revenue: ₹1.67b (up 10% from 3Q 2022). Net income: ₹350.4m (up 38% from 3Q 2022). Profit margin: 21% (up from 17% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in India.공시 • Jan 21Aether Industries Limited (NSEI:AETHER) acquired Industrial premises in Gujarat.Aether Industries Limited (NSEI:AETHER) acquired Industrial premises in Gujarat on January 20, 2023. The transaction will be funded by internal accruals and funding from banks. Aether Industries Limited (NSEI:AETHER) Completed the acquisition of Industrial premises in Gujarat on January 20, 2023.공시 • Jan 02Aether Industries Limited to Report Q3, 2023 Results on Jan 20, 2023Aether Industries Limited announced that they will report Q3, 2023 results on Jan 20, 2023Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: ₹2.19 (vs ₹2.27 in 2Q 2022)Second quarter 2023 results: EPS: ₹2.19. Revenue: ₹1.40b (flat on 2Q 2022). Net income: ₹272.0m (up 8.0% from 2Q 2022). Profit margin: 19% (up from 18% in 2Q 2022). Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in India.Reported Earnings • Nov 13Second quarter 2023 earnings released: EPS: ₹2.19 (vs ₹24.93 in 2Q 2022)Second quarter 2023 results: EPS: ₹2.19. Revenue: ₹1.47b (up 1.5% from 2Q 2022). Net income: ₹272.0m (up 8.0% from 2Q 2022). Profit margin: 19% (up from 17% in 2Q 2022). Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in India.공시 • Nov 05Aether Industries Limited to Report Q2, 2023 Results on Nov 11, 2022Aether Industries Limited announced that they will report Q2, 2023 results on Nov 11, 2022Reported Earnings • Jul 27First quarter 2023 earnings released: EPS: ₹2.46 (vs ₹3.34 in 1Q 2022)First quarter 2023 results: EPS: ₹2.46 (down from ₹3.34 in 1Q 2022). Revenue: ₹1.63b (up 8.3% from 1Q 2022). Net income: ₹306.2m (down 5.3% from 1Q 2022). Profit margin: 19% (down from 22% in 1Q 2022). The decrease in margin was driven by higher expenses.공시 • Jul 26Aether Industries Limited, Annual General Meeting, Sep 27, 2022Aether Industries Limited, Annual General Meeting, Sep 27, 2022.공시 • Jul 19Aether Industries Limited to Report Q1, 2023 Results on Jul 25, 2022Aether Industries Limited announced that they will report Q1, 2023 results on Jul 25, 2022공시 • Jun 17Aether Industries Limited Approves Committee ChangesThe board of Aether Industries Limited in their Meeting held on 16th June, 2022, approved the resignation of Ms. Purnima Ashwin Desai and appointment of Mr. Jitendra Popatlal Vakharia as the audit committee member.Reported Earnings • Jun 17Third quarter 2022 earnings releasedThird quarter 2022 results: EPS: ₹2.28. Revenue: ₹1.51b (flat on 3Q 2021). Net income: ₹254.0m (up ₹254.0m from 3Q 2021). Profit margin: 17% (up from null in 3Q 2021).공시 • Jun 09Aether Industries Limited to Report Q4, 2022 Results on Jun 16, 2022Aether Industries Limited announced that they will report Q4, 2022 results on Jun 16, 2022지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 543534 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: 543534 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Aether Industries 배당 수익률 vs 시장543534의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (543534)n/a시장 하위 25% (IN)0.3%시장 상위 25% (IN)1.5%업계 평균 (Pharmaceuticals)0.7%분석가 예측 (543534) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 543534 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 543534 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 543534 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: 543534 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YIN 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/10 08:13종가2026/06/10 00:00수익2026/03/31연간 수익2026/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Aether Industries Limited는 12명의 분석가가 다루고 있습니다. 이 중 5명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Kumar Saumya SinghAmbit CapitalAshwin MehtaAmbit Capitalnull nullAsian Markets Securities Private Limited9명의 분석가 더 보기
Reported Earnings • May 18Full year 2026 earnings: EPS misses analyst expectationsFull year 2026 results: EPS: ₹16.55 (up from ₹11.95 in FY 2025). Revenue: ₹11.8b (up 41% from FY 2025). Net income: ₹2.19b (up 39% from FY 2025). Profit margin: 19% (in line with FY 2025). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 5.0%. Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Pharmaceuticals industry in India. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.
공시 • May 05Aether Industries Limited to Report Q4, 2026 Results on May 15, 2026Aether Industries Limited announced that they will report Q4, 2026 results on May 15, 2026
Valuation Update With 7 Day Price Move • Mar 20Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,161, the stock trades at a forward P/E ratio of 54x. Average forward P/E is 26x in the Pharmaceuticals industry in India. Total returns to shareholders of 31% over the past three years.
Price Target Changed • Feb 05Price target increased by 10.0% to ₹1,154Up from ₹1,049, the current price target is an average from 5 analysts. New target price is 13% above last closing price of ₹1,023. Stock is up 20% over the past year. The company is forecast to post earnings per share of ₹17.58 for next year compared to ₹11.95 last year.
Reported Earnings • Feb 04Third quarter 2026 earnings: EPS and revenues exceed analyst expectationsThird quarter 2026 results: EPS: ₹4.86 (up from ₹3.27 in 3Q 2025). Revenue: ₹3.17b (up 44% from 3Q 2025). Net income: ₹644.8m (up 49% from 3Q 2025). Profit margin: 20% (in line with 3Q 2025). Revenue exceeded analyst estimates by 10.0%. Earnings per share (EPS) also surpassed analyst estimates by 19%. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Pharmaceuticals industry in India. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
공시 • Jan 21Aether Industries Limited to Report Q3, 2026 Results on Feb 03, 2026Aether Industries Limited announced that they will report Q3, 2026 results on Feb 03, 2026
Valuation Update With 7 Day Price Move • Jan 06Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹1,000, the stock trades at a forward P/E ratio of 52x. Average forward P/E is 28x in the Pharmaceuticals industry in India. Total returns to shareholders of 16% over the past three years.
Valuation Update With 7 Day Price Move • Nov 20Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹893, the stock trades at a forward P/E ratio of 46x. Average forward P/E is 28x in the Pharmaceuticals industry in India. Total loss to shareholders of 2.1% over the past three years.
Reported Earnings • Nov 14Second quarter 2026 earnings released: EPS: ₹4.07 (vs ₹2.63 in 2Q 2025)Second quarter 2026 results: EPS: ₹4.07 (up from ₹2.63 in 2Q 2025). Revenue: ₹2.84b (up 43% from 2Q 2025). Net income: ₹539.6m (up 55% from 2Q 2025). Profit margin: 19% (up from 18% in 2Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in India. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
공시 • Oct 04Aether Industries Limited to Report Q2, 2026 Results on Nov 13, 2025Aether Industries Limited announced that they will report Q2, 2026 results on Nov 13, 2025
Reported Earnings • Jul 25First quarter 2026 earnings: EPS exceeds analyst expectationsFirst quarter 2026 results: EPS: ₹3.55 (up from ₹2.26 in 1Q 2025). Revenue: ₹2.59b (up 44% from 1Q 2025). Net income: ₹470.2m (up 57% from 1Q 2025). Profit margin: 18% (up from 17% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.4%. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Pharmaceuticals industry in India. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has fallen by 3% per year.
공시 • Jul 24Aether Industries Limited, Annual General Meeting, Sep 12, 2025Aether Industries Limited, Annual General Meeting, Sep 12, 2025.
공시 • Jun 30Aether Industries Limited to Report Q1, 2026 Results on Jul 24, 2025Aether Industries Limited announced that they will report Q1, 2026 results on Jul 24, 2025
공시 • May 15An undisclosed buyer acquired 6.77% stake in Aether Industries Limited (NSEI:AETHER) from Purnima Ashwin Desai for INR 6.3 billion.An undisclosed buyer acquired 6.77% stake in Aether Industries Limited (NSEI:AETHER) from Purnima Ashwin Desai for INR 6.3 billion on May 14, 2025. A cash consideration valued at INR 700 per share will be paid for 8.979173 million shares. An undisclosed buyer completed the acquisition of 6.77% stake in Aether Industries Limited (NSEI:AETHER) from Purnima Ashwin Desai on May 14, 2025.
New Risk • May 08New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 27% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. This is currently the only risk that has been identified for the company.
Reported Earnings • May 03Full year 2025 earnings: EPS and revenues exceed analyst expectationsFull year 2025 results: EPS: ₹11.95 (up from ₹6.31 in FY 2024). Revenue: ₹8.80b (up 47% from FY 2024). Net income: ₹1.58b (up 92% from FY 2024). Profit margin: 18% (up from 14% in FY 2024). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) also surpassed analyst estimates by 4.7%. Revenue is forecast to grow 28% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Pharmaceuticals industry in India.
공시 • Apr 26Aether Industries Limited to Report Q4, 2025 Results on May 02, 2025Aether Industries Limited announced that they will report Q4, 2025 results on May 02, 2025
Board Change • Apr 09Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. 4 highly experienced directors. Non-Executive Independent Director Rajkumar Borana was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
공시 • Jan 17Aether Industries Limited Provides Revenue Guidance for the Financial Year 2024Aether Industries Limited provided revenue guidance for the financial year 2024. The company anticipates net financial year to close to reach a revenue of INR 400 million.
공시 • Jan 09Aether Industries Limited Announces Revocation Order from GPCB for Resumption of Operations at Manufacturing Facility IIAether Industries Limited announced that the Gujarat Pollution Control Board (GPCB), through its communication received January 9, 2025, has revoked the closure order issued on November 29, 2023, following the fire incident, for Manufacturing Facility II. Consequently, the facility is now approved for 100% resumption of operations. The Company will commence full-capacity operations at Manufacturing Facility II upon ensuring compliance with the stipulated conditions.
공시 • Jan 01Aether Industries Limited to Report Q3, 2025 Results on Jan 17, 2025Aether Industries Limited announced that they will report Q3, 2025 results on Jan 17, 2025
Board Change • Dec 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. 4 highly experienced directors. Non-Executive Independent Director Rajkumar Borana was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 19Second quarter 2025 earnings released: EPS: ₹2.87 (vs ₹2.77 in 2Q 2024)Second quarter 2025 results: EPS: ₹2.87 (up from ₹2.77 in 2Q 2024). Revenue: ₹2.09b (up 27% from 2Q 2024). Net income: ₹380.7m (up 3.8% from 2Q 2024). Profit margin: 18% (down from 22% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 36% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in India.
공시 • Oct 04Aether Industries Limited to Report Q2, 2025 Results on Oct 18, 2024Aether Industries Limited announced that they will report Q2, 2025 results on Oct 18, 2024
공시 • Jul 22Aether Industries Limited, Annual General Meeting, Sep 10, 2024Aether Industries Limited, Annual General Meeting, Sep 10, 2024.
Reported Earnings • Jul 21First quarter 2025 earnings released: EPS: ₹2.26 (vs ₹2.25 in 1Q 2024)First quarter 2025 results: EPS: ₹2.26 (up from ₹2.25 in 1Q 2024). Revenue: ₹1.80b (up 12% from 1Q 2024). Net income: ₹299.3m (flat on 1Q 2024). Profit margin: 17% (down from 19% in 1Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 33% p.a. on average during the next 3 years, compared to a 9.9% growth forecast for the Pharmaceuticals industry in India.
공시 • Jul 04Aether Industries Limited to Report Q1, 2025 Results on Jul 19, 2024Aether Industries Limited announced that they will report Q1, 2025 results on Jul 19, 2024
New Risk • Jun 05New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 14% Last year net profit margin: 20% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (37% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (14% net profit margin). Shareholders have been diluted in the past year (6.5% increase in shares outstanding).
Reported Earnings • Feb 02Third quarter 2024 earnings released: EPS: ₹1.32 (vs ₹2.81 in 3Q 2023)Third quarter 2024 results: EPS: ₹1.32 (down from ₹2.81 in 3Q 2023). Revenue: ₹1.67b (flat on 3Q 2023). Net income: ₹174.3m (down 50% from 3Q 2023). Profit margin: 11% (down from 21% in 3Q 2023). Revenue is forecast to grow 36% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Pharmaceuticals industry in India.
공시 • Jan 16Aether Industries Limited to Report Q3, 2024 Results on Feb 01, 2024Aether Industries Limited announced that they will report Q3, 2024 results on Feb 01, 2024
Reported Earnings • Nov 02Second quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2024 results: EPS: ₹2.77 (up from ₹2.19 in 2Q 2023). Revenue: ₹1.78b (up 27% from 2Q 2023). Net income: ₹366.8m (up 35% from 2Q 2023). Profit margin: 21% (up from 19% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 7.5%. Earnings per share (EPS) exceeded analyst estimates by 11%. Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Pharmaceuticals industry in India.
공시 • Oct 20Aether Industries Limited to Report Q2, 2024 Results on Oct 31, 2023Aether Industries Limited announced that they will report Q2, 2024 results on Oct 31, 2023
Reported Earnings • Jul 27First quarter 2024 earnings released: EPS: ₹2.25 (vs ₹2.46 in 1Q 2023)First quarter 2024 results: EPS: ₹2.25 (down from ₹2.46 in 1Q 2023). Revenue: ₹1.61b (flat on 1Q 2023). Net income: ₹298.1m (down 2.6% from 1Q 2023). Profit margin: 19% (in line with 1Q 2023). Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Pharmaceuticals industry in India.
공시 • Jul 12Aether Industries Limited to Report Q1, 2024 Results on Jul 26, 2023Aether Industries Limited announced that they will report Q1, 2024 results on Jul 26, 2023
New Risk • Jun 24New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 6.5% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (60% accrual ratio). Minor Risk Shareholders have been diluted in the past year (6.5% increase in shares outstanding).
공시 • Jun 24Aether Industries Limited has completed a Follow-on Equity Offering in the amount of INR 7.5 billion.Aether Industries Limited has completed a Follow-on Equity Offering in the amount of INR 7.5 billion. Security Name: Equity Shares Security Type: Common Stock Securities Offered: 8,012,820 Price\Range: INR 936 Transaction Features: Regulation S; Subsequent Direct Listing
Reported Earnings • May 08Full year 2023 earnings released: EPS: ₹10.47 (vs ₹9.67 in FY 2022)Full year 2023 results: EPS: ₹10.47 (up from ₹9.67 in FY 2022). Revenue: ₹6.68b (up 13% from FY 2022). Net income: ₹1.30b (up 20% from FY 2022). Profit margin: 20% (up from 18% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 28% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Pharmaceuticals industry in India.
공시 • May 07Aether Industries Limited, Annual General Meeting, Jun 16, 2023Aether Industries Limited, Annual General Meeting, Jun 16, 2023.
Reported Earnings • Jan 22Third quarter 2023 earnings released: EPS: ₹2.81 (vs ₹2.28 in 3Q 2022)Third quarter 2023 results: EPS: ₹2.81 (up from ₹2.28 in 3Q 2022). Revenue: ₹1.67b (up 10% from 3Q 2022). Net income: ₹350.4m (up 38% from 3Q 2022). Profit margin: 21% (up from 17% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in India.
공시 • Jan 21Aether Industries Limited (NSEI:AETHER) acquired Industrial premises in Gujarat.Aether Industries Limited (NSEI:AETHER) acquired Industrial premises in Gujarat on January 20, 2023. The transaction will be funded by internal accruals and funding from banks. Aether Industries Limited (NSEI:AETHER) Completed the acquisition of Industrial premises in Gujarat on January 20, 2023.
공시 • Jan 02Aether Industries Limited to Report Q3, 2023 Results on Jan 20, 2023Aether Industries Limited announced that they will report Q3, 2023 results on Jan 20, 2023
Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: ₹2.19 (vs ₹2.27 in 2Q 2022)Second quarter 2023 results: EPS: ₹2.19. Revenue: ₹1.40b (flat on 2Q 2022). Net income: ₹272.0m (up 8.0% from 2Q 2022). Profit margin: 19% (up from 18% in 2Q 2022). Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in India.
Reported Earnings • Nov 13Second quarter 2023 earnings released: EPS: ₹2.19 (vs ₹24.93 in 2Q 2022)Second quarter 2023 results: EPS: ₹2.19. Revenue: ₹1.47b (up 1.5% from 2Q 2022). Net income: ₹272.0m (up 8.0% from 2Q 2022). Profit margin: 19% (up from 17% in 2Q 2022). Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in India.
공시 • Nov 05Aether Industries Limited to Report Q2, 2023 Results on Nov 11, 2022Aether Industries Limited announced that they will report Q2, 2023 results on Nov 11, 2022
Reported Earnings • Jul 27First quarter 2023 earnings released: EPS: ₹2.46 (vs ₹3.34 in 1Q 2022)First quarter 2023 results: EPS: ₹2.46 (down from ₹3.34 in 1Q 2022). Revenue: ₹1.63b (up 8.3% from 1Q 2022). Net income: ₹306.2m (down 5.3% from 1Q 2022). Profit margin: 19% (down from 22% in 1Q 2022). The decrease in margin was driven by higher expenses.
공시 • Jul 26Aether Industries Limited, Annual General Meeting, Sep 27, 2022Aether Industries Limited, Annual General Meeting, Sep 27, 2022.
공시 • Jul 19Aether Industries Limited to Report Q1, 2023 Results on Jul 25, 2022Aether Industries Limited announced that they will report Q1, 2023 results on Jul 25, 2022
공시 • Jun 17Aether Industries Limited Approves Committee ChangesThe board of Aether Industries Limited in their Meeting held on 16th June, 2022, approved the resignation of Ms. Purnima Ashwin Desai and appointment of Mr. Jitendra Popatlal Vakharia as the audit committee member.
Reported Earnings • Jun 17Third quarter 2022 earnings releasedThird quarter 2022 results: EPS: ₹2.28. Revenue: ₹1.51b (flat on 3Q 2021). Net income: ₹254.0m (up ₹254.0m from 3Q 2021). Profit margin: 17% (up from null in 3Q 2021).
공시 • Jun 09Aether Industries Limited to Report Q4, 2022 Results on Jun 16, 2022Aether Industries Limited announced that they will report Q4, 2022 results on Jun 16, 2022